1887
Letter Open Access
Like 0
Preview this article:
Zoom in
Zoomout

Authors’ reply: A norovirus intervariant GII.4 recombinant in Victoria, Australia, June 2016: the next epidemic variant? Reflections and a note of caution, Page 1 of 1

| /docserver/preview/fulltext/eurosurveillance/21/41/eurosurv-21-30373-4-1.gif

There is no abstract available for this article.
Use the preview function to the left.

Loading

Article metrics loading...

/content/10.2807/1560-7917.ES.2016.21.41.30373
2016-10-13
2017-12-12
http://instance.metastore.ingenta.com/content/10.2807/1560-7917.ES.2016.21.41.30373
Loading
Loading full text...

Full text loading...

/deliver/fulltext/eurosurveillance/21/41/eurosurv-21-30373-4.html?itemId=/content/10.2807/1560-7917.ES.2016.21.41.30373&mimeType=html&fmt=ahah

References

  1. Bruggink L, Catton M, Marshall J. A norovirus intervariant GII.4 recombinant in Victoria, Australia, June 2016: the next epidemic variant? Euro Surveill. 2016;21(39):pii=30353. http://dx.doi.org/10.2807/1560-7917.ES.2016.21.39.30353
  2. Fonager J, Barzinci S, Fischer TK. Emergence of a new recombinant Sydney 2012 norovirus variant in Denmark, 26 December 2012 to 22 March 2013. Euro Surveill. 2013;18(25):20506.  https://doi.org/10.2807/1560-7917.ES2013.18.25.20506  PMID: 23806295 
  3. Centers for Disease Control and Prevention (CDC). CaliciNet Data. Atlanta, GA: CDC. [Accessed 28 Sep 2016]. Available from: http://www.cdc.gov/norovirus/reporting/calicinet/data.html
  4. Barba M, Daly JM. The influenza NS1 protein: what do we know in equine influenza virus pathogenesis? Pathogens. 2016;5(3). pii: E57.  https://doi.org/10.3390/pathogens5030057  PMID: 27589809 
Comment has been disabled for this content
Submit comment
Close
Comment moderation successfully completed
This is a required field
Please enter a valid email address
Approval was a Success
Invalid data
An Error Occurred
Approval was partially successful, following selected items could not be processed due to error